These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36404585)

  • 1. Yellow Fever: A Perennial Threat.
    Tuells J; Henao-Martínez AF; Franco-Paredes C
    Arch Med Res; 2022 Nov; 53(7):649-657. PubMed ID: 36404585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow fever in the diagnostics laboratory.
    Domingo C; Charrel RN; Schmidt-Chanasit J; Zeller H; Reusken C
    Emerg Microbes Infect; 2018 Jul; 7(1):129. PubMed ID: 30002363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yellow fever: the recurring plague.
    Tomori O
    Crit Rev Clin Lab Sci; 2004; 41(4):391-427. PubMed ID: 15487593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Risk and Elimination of Yellow Fever Epidemics.
    Ndeffo-Mbah ML; Pandey A
    J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yellow fever: a reemerging threat.
    Gardner CL; Ryman KD
    Clin Lab Med; 2010 Mar; 30(1):237-60. PubMed ID: 20513550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
    Baba MM; Ikusemoran M
    Biochem Biophys Res Commun; 2017 Oct; 492(4):548-557. PubMed ID: 28109882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
    Monath TP; Nasidi A
    Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The second coming of urban yellow fever in the Americas: looking the past to see the future.
    Salomón OD; Arias AR
    An Acad Bras Cienc; 2022; 94(2):e20201252. PubMed ID: 35730861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, drivers and global health implications of the 2019/2020 yellow fever sporadic outbreaks in Sub-Saharan Africa.
    Uchenna Emeribe A; Nasir Abdullahi I; O R Ajagbe O; Egede Ugwu C; Oloche Onoja S; Dahiru Abubakar S; Modesta Umeozuru C; Sunday Animasaun O; Omoruyi Omosigho P; Mukhtar Danmusa U; Alhaji Baba Mallam M; Saidu Aminu M; Yahaya H; Oyewusi S
    Pathog Dis; 2021 Apr; 79(4):. PubMed ID: 33739369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.
    Shearer FM; Longbottom J; Browne AJ; Pigott DM; Brady OJ; Kraemer MUG; Marinho F; Yactayo S; de Araújo VEM; da Nóbrega AA; Fullman N; Ray SE; Mosser JF; Stanaway JD; Lim SS; Reiner RC; Moyes CL; Hay SI; Golding N
    Lancet Glob Health; 2018 Mar; 6(3):e270-e278. PubMed ID: 29398634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional-dose yellow fever vaccination: how much more can we do with less?
    Visser LG
    Curr Opin Infect Dis; 2019 Oct; 32(5):390-393. PubMed ID: 31335440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.
    Jentes ES; Han P; Gershman MD; Rao SR; LaRocque RC; Staples JE; Ryan ET; The Global TravEpiNet Consortium
    Am J Trop Med Hyg; 2013 May; 88(5):954-961. PubMed ID: 23458961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever vaccine: an effective vaccine for travelers.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2014; 10(1):126-8. PubMed ID: 24056028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yellow fever vaccine: past, present and future.
    Roukens AH; Visser LG
    Expert Opin Biol Ther; 2008 Nov; 8(11):1787-95. PubMed ID: 18847312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological description of and response to a large yellow fever outbreak in Edo state Nigeria, September 2018 - January 2019.
    Nwachukwu William E; Oladejo J; Ofoegbunam CM; Anueyiagu C; Dogunro F; Etiki SO; Dachung BI; Obiekea C; Aderoju B; Akanbi K; Adeyemi IT; Famokun GA; Emelife O; Osamwonyi IW; Ochu CL; Abiode A; Ireye F; Chukwuji M; Ipadeola O; Saiki M; Okudo I; Nwodo D; Oteri JA; Ilori E; Mba N; Ihekweazu C
    BMC Public Health; 2022 Aug; 22(1):1644. PubMed ID: 36042438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever as an endemic/epidemic disease and priorities for vaccination.
    Monath TP
    Bull Soc Pathol Exot; 2006 Dec; 99(5):341-7. PubMed ID: 17253051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing epidemiology of yellow fever virus in Oyo State, Nigeria.
    Bassey BE; Braka F; Onyibe R; Kolude OO; Oluwadare M; Oluwabukola A; Omotunde O; Iyanda OA; Tella AA; Olanike OS
    BMC Public Health; 2022 Mar; 22(1):467. PubMed ID: 35260123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow fever, Asia and the East African slave trade.
    Cathey JT; Marr JS
    Trans R Soc Trop Med Hyg; 2014 May; 108(5):252-7. PubMed ID: 24743951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's Old Is New Again: The Re-emergence of Yellow Fever in Brazil and Vaccine Shortages.
    Chen LH; Kozarsky PE; Visser LG
    Clin Infect Dis; 2019 May; 68(10):1761-1762. PubMed ID: 30204852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.